These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 546729)

  • 21. Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro.
    Larsen B; Heron I; Thorling EB
    Eur J Cancer (1965); 1980 Mar; 16(3):415-21. PubMed ID: 6445273
    [No Abstract]   [Full Text] [Related]  

  • 22. [Correlation between serum values of copper, ceruloplasmin, SMAO, SDAO, in health- subjects, in pregnant women and in some pathological conditions (author's transl)].
    Bombardieri G; Rossi L; Bevilacqua E; Fabiani S; Tettamanti P
    Quad Sclavo Diagn; 1976 Jun; 12(2):131-47. PubMed ID: 828961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma copper and zinc levels in Hodgkin's disease].
    Cappelaere P; Sulman C; Chechan C; Gosselin-Dulaquais P
    Lille Med; 1975 Dec; 20(10):904-13. PubMed ID: 1207358
    [No Abstract]   [Full Text] [Related]  

  • 24. Alterations of plasma levels in malignant lymphoma.
    Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
    Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
    Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
    Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of copper oxidase (ceruloplasmin) and related tests in Hodgkin's disease.
    Wolf PL; Ray G; Kaplan H
    Clin Biochem; 1979 Dec; 12(6):202-4. PubMed ID: 535145
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnostic value of copper, haptoglobin and alpha-2-globulin in the serum of patients with Hodgkin's disease].
    Cepelja Z; Grgić Z; Markinković M; Ivanov D
    Lijec Vjesn; 1975 May; 97(5):289-93. PubMed ID: 54857
    [No Abstract]   [Full Text] [Related]  

  • 29. Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease.
    Jelliffe AM
    Natl Cancer Inst Monogr; 1973 May; 36():325-6. PubMed ID: 4744592
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood protein, iron and copper, and leukocyte alkaline phosphatase in lymphoma].
    Martinetto P; Neretto G; Agricola R; Pellerito R; Giovanelli E; Fassio D
    Arch Sci Med (Torino); 1980; 137(1):119-26. PubMed ID: 7458644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavior of total serum complement in Hodgkin's disease and other malignant lymphomas.
    ROTTINO A; LEVY AL
    Blood; 1959 Mar; 14(3):246-54. PubMed ID: 13628822
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in serum copper and serum ceruloplasmin concentration induced by surgical trauma.
    Hallböök T; Hedelin H
    Acta Chir Scand; 1980; 146(6):371-3. PubMed ID: 7468069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma.
    Kamthan M; Joshi N; Sharma ML
    Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Behavior and prognostic significance of serum ceruloplasmin in relation to the histopathological aspect of Hodgkin's disease].
    Pisi E; Di Feliciantonio R; Figus E; Ferri S
    Minerva Med; 1968 Feb; 59(17):944-52. PubMed ID: 5652623
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood iron and blood copper in acute and chronic leukemia and in Hodgkin's disease].
    RECHENBERGER J
    Dtsch Z Verdau Stoffwechselkr; 1957 Apr; 17(2):78-85. PubMed ID: 13437842
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum copper, ceruloplasmin and thiobarbituric acid reactive substance status in patients with ovarian cancer.
    Nayak SB; Bhat VR; Mayya SS
    Indian J Physiol Pharmacol; 2004 Oct; 48(4):486-8. PubMed ID: 15907060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [VARIATIONS IN SERUM COPPER OXIDASE (CERULOPLASMIN) IN THE COURSE OF MALIGNANT LYMPHOGRANULOMATOSIS].
    ZAMFIRESCU-GHEORGHIU M; PETRESCU M; GROZEA P; GOCIU M; SIGHETEA E; VLADESCU C; CUCU F
    Stud Cercet Med Interna; 1964; 5(3):263-7. PubMed ID: 14203689
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.